Severe Late-Onset Drug-Induced Immune Thrombocytopenia Following IFN β-1a Treatment: A Case Report of a 52-Year-Old Woman with Relapse-Remitting Multiple Sclerosis

Interferon β-1a (IFNβ1a) is considered safe in relapsing-remitting multiple sclerosis (RRMS). Drug-induced thrombocytopenia (DITP) is a rare but underreported adverse event that is often confused with other causes of thrombocytopenia. We report the case of a 52-year-old woman who developed limb and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cisarovsky, Christophe, Théaudin, Marie, Bart, Pierre-Alexandre, Stalder, Grégoire, Alberio, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715335/
https://www.ncbi.nlm.nih.gov/pubmed/36467669
http://dx.doi.org/10.1155/2022/2767031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715335/
https://www.ncbi.nlm.nih.gov/pubmed/36467669
http://dx.doi.org/10.1155/2022/2767031

Ejemplares similares